NCT00653393

Bioavailability Study of Tranylcypromine 10mg Tablets Under Fasting Conditions

To Compare Bioavailability of Kali Tranylcypromine 10mg Tablets to That of Parnate 10 mg Tablets Under Fasting Conditions.

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 39 (actual)
• Sponsor: Par Pharmaceutical, Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

To compare the single-dose Bioavailability of Tranylcypromine and Parnate

Detailed description

To compare the relative Bioavailability of Tranylcypromine 10 mg tablets with that of PARNATE 10mg tablets in normal,healthy, men and women under fasting conditions

Conditions

• To Determine the Bioavailability of Tranylcypromine

Interventions

Type	Name	Description
DRUG	Tranylcypromine	Tablets, 10 mg, single-dose
DRUG	Parnate	Tablets, 10 mg, single-dose

Timeline

• Start date: 2004-10-01
• Primary completion: 2004-11-01
• Completion: 2004-12-01
• First posted: 2008-04-04
• Last updated: 2008-04-04

Locations

1 site across 1 country: United States